Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cong Xue

Showing results (81-90 of 159) with videos related to

Pageof 16
Sort By:
Plos One|February 6, 2013
Prognostic significance of the combined score of endothelial expression of nucleolin and CD31 in surgically resected non-small cell lung cancerHongyun Zhao, Yan Huang, Cong Xue, et al.
Oncotarget|December 29, 2016
Tumor-infiltrating lymphocytes predict prognosis of breast cancer patients treated with anti-Her-2 therapyTan-Huan Chen, Ying-Chun Zhang, Yu-Ting Tan, et al.
Chinese Journal of Cancer|June 14, 2012
Expression of RRM1 and its association with resistancy to gemcitabine-based chemotherapy in advanced nasopharyngeal carcinomaLi-Ping Zhao, Cong Xue, Jian-Wei Zhang, et al.
Medicine|January 15, 2016
Personalized Estimate of Chemotherapy-Induced Nausea and Vomiting: Development and External Validation of a Nomogram in Cancer Patients Receiving Highly/Moderately Emetogenic ChemotherapyZhihuang Hu, Wenhua Liang, Yunpeng Yang, et al.
Cancer Chemotherapy and Pharmacology|May 24, 2017
The renal safety and efficacy of combined gemcitabine plus cisplatin and gemcitabine plus carboplatin chemotherapy in Chinese patients with a solitary kidney after nephroureterectomyPeng Sun, Cong Xue, Li-Ren Li, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 10, 2025
Construction of Hollow Structured Covalent Organic Framework with Chiral Internal Catalytic Sites for Asymmetric HydrogenationJian-Cheng Wang, Hua Qiao, Zhi Chen, et al.
Therapeutic Advances in Medical Oncology|May 19, 2026
Dynamic inflammatory biomarkers as prognostic indicators in advanced breast cancer patients receiving PD-1 inhibitorsNa Wang, Peijun Yi, Qianyi Lu, et al.
Oncotargets and Therapy|December 20, 2012
Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinibFei Xu, Jingxun Wu, Cong Xue, et al.
Virus Research|May 31, 2017
Identification and pathotypical analysis of a novel VIk sub-genotype Newcastle disease virus obtained from pigeon in ChinaCong Xue, Xiaohong Xu, Renfu Yin, et al.
Journal of Translational Medicine|January 13, 2025
Impacts of genomic alterations on the efficacy of HER2-targeted antibody-drug conjugates in patients with metastatic breast cancerRiqing Huang, Anqi Hu, Qixiang Rong, et al.
Pageof 16

Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
Plos One|February 6, 2013
Prognostic significance of the combined score of endothelial expression of nucleolin and CD31 in surgically resected non-small cell lung cancerHongyun Zhao, Yan Huang, Cong Xue, et al.
Oncotarget|December 29, 2016
Tumor-infiltrating lymphocytes predict prognosis of breast cancer patients treated with anti-Her-2 therapyTan-Huan Chen, Ying-Chun Zhang, Yu-Ting Tan, et al.
Chinese Journal of Cancer|June 14, 2012
Expression of RRM1 and its association with resistancy to gemcitabine-based chemotherapy in advanced nasopharyngeal carcinomaLi-Ping Zhao, Cong Xue, Jian-Wei Zhang, et al.
Medicine|January 15, 2016
Personalized Estimate of Chemotherapy-Induced Nausea and Vomiting: Development and External Validation of a Nomogram in Cancer Patients Receiving Highly/Moderately Emetogenic ChemotherapyZhihuang Hu, Wenhua Liang, Yunpeng Yang, et al.
Cancer Chemotherapy and Pharmacology|May 24, 2017
The renal safety and efficacy of combined gemcitabine plus cisplatin and gemcitabine plus carboplatin chemotherapy in Chinese patients with a solitary kidney after nephroureterectomyPeng Sun, Cong Xue, Li-Ren Li, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 10, 2025
Construction of Hollow Structured Covalent Organic Framework with Chiral Internal Catalytic Sites for Asymmetric HydrogenationJian-Cheng Wang, Hua Qiao, Zhi Chen, et al.
Therapeutic Advances in Medical Oncology|May 19, 2026
Dynamic inflammatory biomarkers as prognostic indicators in advanced breast cancer patients receiving PD-1 inhibitorsNa Wang, Peijun Yi, Qianyi Lu, et al.
Oncotargets and Therapy|December 20, 2012
Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinibFei Xu, Jingxun Wu, Cong Xue, et al.
Virus Research|May 31, 2017
Identification and pathotypical analysis of a novel VIk sub-genotype Newcastle disease virus obtained from pigeon in ChinaCong Xue, Xiaohong Xu, Renfu Yin, et al.
Journal of Translational Medicine|January 13, 2025
Impacts of genomic alterations on the efficacy of HER2-targeted antibody-drug conjugates in patients with metastatic breast cancerRiqing Huang, Anqi Hu, Qixiang Rong, et al.
Pageof 16